{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:19:08Z","timestamp":1761218348039,"version":"3.40.5"},"reference-count":39,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Acta Neuropsychiatr."],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0924270821000041_as1\"><jats:title>Objective:<\/jats:title><jats:p>To investigate the long-term effects of juvenile sub-chronic sildenafil (SIL) treatment on the depressive-like behaviour and hippocampal brain-derived neurotrophic factor (BDNF) levels of adult Sprague-Dawley (SD) versus Flinders Sensitive Line (FSL) rats.<\/jats:p><\/jats:sec><jats:sec id=\"S0924270821000041_as2\"><jats:title>Methods:<\/jats:title><jats:p>SD and FSL rats were divided into pre-pubertal and pubertal groups, whereafter 14-day saline or SIL treatment was initiated. Pre-pubertal and pubertal rats were treated from postnatal day 21 (PND21) and PND35, respectively. The open field and forced swim tests (FST) were performed on PND60, followed by hippocampal BDNF level analysis 1 day later.<\/jats:p><\/jats:sec><jats:sec id=\"S0924270821000041_as3\"><jats:title>Results:<\/jats:title><jats:p>FSL rats displayed greater immobility in the FST compared to SD rats (<jats:italic>p<\/jats:italic> &lt; 0.0001), which was reduced by SIL (<jats:italic>p<\/jats:italic> &lt; 0.0001), regardless of treatment period. Hippocampal BDNF levels were unaltered by SIL in all treatment groups (<jats:italic>p<\/jats:italic> &gt; 0.05).<\/jats:p><\/jats:sec><jats:sec id=\"S0924270821000041_as4\"><jats:title>Conclusion:<\/jats:title><jats:p>Juvenile sub-chronic SIL treatment reduces the risk of depressive-like behaviour manifesting during young adulthood in genetically susceptible rats.<\/jats:p><\/jats:sec>","DOI":"10.1017\/neu.2021.4","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T09:02:07Z","timestamp":1613552527000},"page":"200-205","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":4,"title":["The long-term bio-behavioural effects of juvenile sildenafil treatment in Sprague-Dawley versus flinders sensitive line rats"],"prefix":"10.1017","volume":"33","author":[{"given":"Juandr\u00e9 Lambertus Bernardus","family":"Saayman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0023-9711","authenticated-orcid":false,"given":"Stephanus Frederik","family":"Steyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2707-1258","authenticated-orcid":false,"given":"Christiaan Beyers","family":"Brink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"volume-title":"Chronic Effects of Pre-Adolescent Pharmacological and Non-Pharmacological Interventions on Depressive-Like Behaviour in Rats.","year":"2018","author":"Steyn","key":"S0924270821000041_ref33"},{"key":"S0924270821000041_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2006.01.033"},{"key":"S0924270821000041_ref25","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291711002066"},{"key":"S0924270821000041_ref30","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301574"},{"key":"S0924270821000041_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2007.01.028"},{"key":"S0924270821000041_ref2","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145703003468"},{"key":"S0924270821000041_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2010.01.032"},{"key":"S0924270821000041_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2016.05.042"},{"key":"S0924270821000041_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2005.03.015"},{"key":"S0924270821000041_ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2017.01.043"},{"key":"S0924270821000041_ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.05.050"},{"key":"S0924270821000041_ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-009-9523-1"},{"key":"S0924270821000041_ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-007-0806-5"},{"key":"S0924270821000041_ref38","unstructured":"WHO (2017) World Health Organization. Depression and other common mental disorders: global health estimates. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/254610\/WHO-MSD-MER-2017.2-eng.pdf?sequence=1&isAllowed=y. (accessed 24 January 2021)."},{"key":"S0924270821000041_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.09.021"},{"key":"S0924270821000041_ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2015.00089"},{"key":"S0924270821000041_ref11","unstructured":"FDA (2014) Food and Drug Administration. Don\u2019t Leave Childhood Depression Untreated. Available at https:\/\/www.fda.gov\/consumers\/consumer-updates\/fda-dont-leave-childhood-depression-untreated (accessed 23 November 2020)."},{"key":"S0924270821000041_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2012.10.048"},{"key":"S0924270821000041_ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hipo.20903"},{"key":"S0924270821000041_ref37","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145709990241"},{"key":"S0924270821000041_ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-014-9533-4"},{"key":"S0924270821000041_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2016.02.001"},{"key":"S0924270821000041_ref20","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e32833befe5"},{"key":"S0924270821000041_ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2018.05.021"},{"key":"S0924270821000041_ref28","unstructured":"NIMH (2018) National Institute of Mental Health. Depression. Available at https:\/\/www.nimh.nih.gov\/health\/topics\/depression\/index.shtml. (accessed 23 November 2020)."},{"key":"S0924270821000041_ref10","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145709990721"},{"key":"S0924270821000041_ref5","doi-asserted-by":"publisher","DOI":"10.1017\/neu.2016.53"},{"key":"S0924270821000041_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2011.05.004"},{"key":"S0924270821000041_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.06.012"},{"key":"S0924270821000041_ref3","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200004270-00044"},{"key":"S0924270821000041_ref8","doi-asserted-by":"publisher","DOI":"10.1177\/0956797613504966"},{"key":"S0924270821000041_ref26","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2018.11.275"},{"key":"S0924270821000041_ref16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002317.pub2"},{"key":"S0924270821000041_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2006.07.002"},{"key":"S0924270821000041_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(03)00005-8"},{"key":"S0924270821000041_ref12","first-page":"1517","article-title":"Depression is the leading cause of disability around the world","volume":"317","author":"Friedrich","year":"2017","journal-title":"JAMA"},{"key":"S0924270821000041_ref35","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.14757"},{"key":"S0924270821000041_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2005.03.008"},{"key":"S0924270821000041_ref19","doi-asserted-by":"publisher","DOI":"10.4306\/pi.2010.7.4.231"}],"container-title":["Acta Neuropsychiatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0924270821000041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T09:36:23Z","timestamp":1625477783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0924270821000041\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0924270821000041"],"URL":"https:\/\/doi.org\/10.1017\/neu.2021.4","relation":{},"ISSN":["0924-2708","1601-5215"],"issn-type":[{"type":"print","value":"0924-2708"},{"type":"electronic","value":"1601-5215"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"assertion":[{"value":"\u00a9 The Author(s), 2021. Published by Cambridge University Press on behalf of Scandinavian College of Neuropsychopharmacology","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}